O. W. Press
M.D.
Pharmaceuticals
PhaseRx, Inc.
Norway
Biography
Dr. Oliver W. Press, M.D., Ph.D. co-founded PhaseRx, Inc. in 2006. Dr. Press serves as a Member of Advisory Board of Trubion Pharmaceuticals Inc. He serves as a Member of Scientific Advisory Board of Algeta ASA. He served as a Member of Scientific Advisory Board at Converge Medical, Inc. Dr. Press is Professor in the Division of Oncology at the University of Washington. Dr. Press is known internationally for his pioneering work within immunotherapy in general and the immunotherapy of non-Hodgkin's Lymphoma in particular.
Research Interest
IMMUNOTHERAPY
